Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Animal research: reporting in vivo experiments--the ARRIVE guidelines.

Literature DB >> 21206507

Animal research: reporting in vivo experiments--the ARRIVE guidelines.

Carol Kilkenny, William Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman.

Abstract

Mesh：

Year: 2011 PMID： 21206507 PMCID： PMC3070981 DOI： 10.1038/jcbfm.2010.220

Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN： 0271-678X Impact factor: 6.200

× No keyword cloud information.

2 in total

Review 1. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors: Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal: PLoS Biol Date: 2010-06-29 Impact factor: 8.029

2. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors: Kenneth F Schulz; Douglas G Altman; David Moher
Journal: BMJ Date: 2010-03-23

2 in total

174 in total

1. Improving the quality of biomedical research: guidelines for reporting experiments involving animals.

Authors: Ulrich Dirnagl; Martin Lauritzen
Journal: J Cereb Blood Flow Metab Date: 2011-01-05 Impact factor: 6.200

2. Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.

Authors: Lydia O Ayanwuyi; Serena Stopponi; Massimo Ubaldi; Andrea Cippitelli; Cinzia Nasuti; Ruslan Damadzic; Markus Heilig; Jesse Schank; Kejun Cheng; Kenner C Rice; Roberto Ciccocioppo
Journal: Br J Pharmacol Date: 2015-10-22 Impact factor: 8.739

3. Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors: Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal: Transl Stroke Res Date: 2017-04-12 Impact factor: 6.829

4. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

Authors: M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
Journal: Br J Pharmacol Date: 2014-07 Impact factor: 8.739

5. Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats.

Authors: Francesco Blasi; Michael J Whalen; Cenk Ayata
Journal: J Cereb Blood Flow Metab Date: 2015-02-04 Impact factor: 6.200

6. Intracranial pressure elevation reduces flow through collateral vessels and the penetrating arterioles they supply. A possible explanation for 'collateral failure' and infarct expansion after ischemic stroke.

Authors: Daniel J Beard; Damian D McLeod; Caitlin L Logan; Lucy A Murtha; Mohammad S Imtiaz; Dirk F van Helden; Neil J Spratt
Journal: J Cereb Blood Flow Metab Date: 2015-02-11 Impact factor: 6.200

Animal research: reporting in vivo experiments--the ARRIVE guidelines.

Review 1. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

2. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

1. Improving the quality of biomedical research: guidelines for reporting experiments involving animals.

2. Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.

3. Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

4. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

5. Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats.

6. Intracranial pressure elevation reduces flow through collateral vessels and the penetrating arterioles they supply. A possible explanation for 'collateral failure' and infarct expansion after ischemic stroke.

7. Stroke Cytoprotection: Can Repeating History with New Expectations Really Be the Path to Success in Stroke Research?

8. Translational Stroke Research Opportunities and a Strategy to Develop Effective Cytoprotection.

9. Relationships among Bone Quality, Implant Osseointegration, and Wnt Signaling.

10. Endogenous Regulatory T Cells Promote M2 Macrophage Phenotype in Diabetic Stroke as Visualized by Optical Imaging.